American Association for Cancer Research
AACR Webcast
AACR-NCI-EORTC International Conference: 2011 Molecular Targets and Cancer Therapeutics
Added
November
2011
AACR Annual Meeting 2012
Added
April
2012
AACR Home | AACR Webcasts Home | Help
 
Attention: Purchased AACR Annual Meeting 2012 webcasts? Your login information was emailed to you on April 30, 2012.
Login for full access:
Your username and password is not your MyAACR account information
Username:  
Password:
Search Webcasts:
 
Search for text in:
Multiple terms:
separate each search terms with a space
Additional Search Filters:
 
Conference years:
check:first | all
Conference:
check:first | all
Access:
Availability:
Participation Type:
check:first | all
 
Browse by: Sort by:
 
<< first | < prev page: of 144 records per page: next > | last >>
 
pages: 1 2 3 4 5 ... 141 142 143 144 presentations: 1 to 25 of 3593
 
Opening Ceremony
Free
All slides included
 
 
Opening Remarks
Margaret Foti, Ph.D., M.D. (h.c.)
American Association for Cancer Research, Philadelphia, PA
President's Remarks
Judy Garber, M.D., M.P.H.
Dana-Farber Cancer Inst., Boston, MA
 
from the AACR Annual Meeting 2012 on April 1, 2012 8:15:00 AM-9:00:00 AM
Sixth Annual AACR Team Science Award
Free
All slides included
 
 
Team Science Award Presentation
The ICR and Royal Marsden Hospital: CRUK Cancer Therapeutics & Drug Development Units
Institute of Cancer Research, Sutton, United Kingdom
 
from the AACR Annual Meeting 2012 on April 1, 2012 8:15:00 AM-9:00:00 AM
Distinguished Service Award
Free
All slides included
 
 
Introduction
Margaret Foti, Ph.D., M.D. (h.c.)
American Association for Cancer Research, Philadelphia, PA
Acceptance Speech
Bayard Clarkson, M.D.
Mem. Sloan-Kettering Cancer Ctr., New York, NY
 
from the AACR Annual Meeting 2012 on April 1, 2012 8:15:00 AM-9:00:00 AM
Tribute to Evelyn H. Lauder
Free
All slides included
 
 
Introduction
Judy Garber, M.D., M.P.H.
Dana-Farber Cancer Inst., Boston, MA
Tribute to Evelyn H. Lauder
Larry Norton, M.D.
Mem. Sloan-Kettering Cancer Ctr., New York, NY
 
from the AACR Annual Meeting 2012 on April 1, 2012 8:15:00 AM-9:00:00 AM
Sixth Annual AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research
Free
All slides included
 
 
Opening Ceremony Award Presentation
John Mendelsohn
UT MD Anderson Cancer Ctr., Houston, TX, United States
 
from the AACR Annual Meeting 2012 on April 1, 2012 8:15:00 AM-9:00:00 AM
Ninth Annual AACR Award for Lifetime Achievement in Cancer Research
 
 
Permission not
granted for webcast
 
 
Acceptance Speech
Beatrice Mintz
Fox Chase Cancer Center, Philadelphia, PA, United States
 
from the AACR Annual Meeting 2012 on April 1, 2012 8:15:00 AM-9:00:00 AM
Honoring 50-year Members and Distinguished Public Service
Free
All slides included
 
 
Introduction of 50-year Members
Judy Garber, M.D., M.P.H.
Dana-Farber Cancer Inst., Boston, MA
Introduction of Distinguished Public Service
Margaret Foti, Ph.D., M.D. (h.c.)
American Association for Cancer Research, Philadelphia, PA
Acceptance Speech
Giuseppe Bernardi, M.D.
Pezcoller Foundation, Trento, Italy
 
from the AACR Annual Meeting 2012 on April 1, 2012 8:15:00 AM-9:00:00 AM
Accelerating Science Video
Free
All slides included
 
 
AACR Annual Meeting 2012 Opening Video
 
from the AACR Annual Meeting 2012 on April 1, 2012 8:15:00 AM-9:00:00 AM
Closing Remarks
Free
All slides included
 
 
Judy Garber, M.D., M.P.H.
Dana-Farber Cancer Inst., Boston, MA
 
from the AACR Annual Meeting 2012 on April 1, 2012 8:15:00 AM-9:00:00 AM
The Cancer Biology Revolution: From Concept to Clinic
Free
All slides included
 
 
Emerging landscape of the tumor genome
Elaine Mardis
Washington Univ. School of Medicine, Saint Louis, MO, United States
 
from the AACR Annual Meeting 2012 on April 1, 2012 9:15:00 AM-12:15:00 PM
The Cancer Biology Revolution: From Concept to Clinic
Free
All slides included
 
 
The genetic basis for cancer therapeutics
William R. Sellers
Novartis Insts. for BioMedical Research, Cambridge, MA, United States
 
from the AACR Annual Meeting 2012 on April 1, 2012 9:15:00 AM-12:15:00 PM
The Cancer Biology Revolution: From Concept to Clinic
Free
Some slides withheld
 
 
Therapeutic targeting of B cell receptor signaling in activated B cell-like (ABC) diffuse large B cell lymphoma with the BTK inhibitor Ibrutinib (PCI-32765)
Louis M Staudt
NCI-CCR, Bethesda, MD, United States
 
from the AACR Annual Meeting 2012 on April 1, 2012 9:15:00 AM-12:15:00 PM
The Cancer Biology Revolution: From Concept to Clinic
Free
All slides withheld
 
 
Discussant
Jonathan D Licht
Northwestern Univ. Lurie Comp. Cancer Ctr., Chicago, IL, United States
 
from the AACR Annual Meeting 2012 on April 1, 2012 9:15:00 AM-12:15:00 PM
The Cancer Biology Revolution: From Concept to Clinic
Free
All slides included
 
 
Mobilizing the immune system to treat cancer: New insights and opportunities
James P. Allison
Mem. Sloan-Kettering Cancer Ctr., New York, NY, United States
 
from the AACR Annual Meeting 2012 on April 1, 2012 9:15:00 AM-12:15:00 PM
The Cancer Biology Revolution: From Concept to Clinic
Free
All slides included
 
 
Human papillomavirus in the etiology and prevention of genital cancers
Nubia Muñoz
Former IARC Epidemiologist, Lyon, France
 
from the AACR Annual Meeting 2012 on April 1, 2012 9:15:00 AM-12:15:00 PM
The Cancer Biology Revolution: From Concept to Clinic
 
 
Permission not
granted for webcast
 
 
Molecular mechanisms of epigenetic inheritance
Danny F. Reinberg
NYU Langone Medical Center, New York, NY, United States
 
from the AACR Annual Meeting 2012 on April 1, 2012 9:15:00 AM-12:15:00 PM
Clinical Trials Symposium 1: Clinical Trials of Agents Directed Towards PI3K and Metabolic Pathways
Free
All slides included
 
 
BYL719, a next generation PI3K alpha specific inhibitor: Preliminary safety, PK, and efficacy results from the first-in-human study
Dejan Juric
Massachusetts General Hospital Cancer Center, Boston, MA, United States
 
from the AACR Annual Meeting 2012 on April 1, 2012 3:15:00 PM-5:25:00 PM
Clinical Trials Symposium 1: Clinical Trials of Agents Directed Towards PI3K and Metabolic Pathways
Free
All slides included
 
 
Discussant
Lillian L. Siu
University Health Network Ontario Cancer Institute, Toronto, ON, Canada
 
from the AACR Annual Meeting 2012 on April 1, 2012 3:15:00 PM-5:25:00 PM
Clinical Trials Symposium 1: Clinical Trials of Agents Directed Towards PI3K and Metabolic Pathways
Free
All slides included
 
 
A phase I, open label, dose escalation study of oral mammalian target of rapamycin inhibitor INK128 administered by intermittent dosing regimens in patients with advanced malignancies
Josep Tabernero
Vall d’Hebron Institue of Oncology, Barcelona, Spain
 
from the AACR Annual Meeting 2012 on April 1, 2012 3:15:00 PM-5:25:00 PM
Clinical Trials Symposium 1: Clinical Trials of Agents Directed Towards PI3K and Metabolic Pathways
Free
All slides included
 
 
Discussant
Fabrice Andre
Institut Gustave Roussy, Villejuif, France
 
from the AACR Annual Meeting 2012 on April 1, 2012 3:15:00 PM-5:25:00 PM
Clinical Trials Symposium 1: Clinical Trials of Agents Directed Towards PI3K and Metabolic Pathways
Free
All slides included
 
 
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer
Funda Meric-Bernstam
UT M.D. Anderson Cancer Ctr., Houston, TX, United States
 
from the AACR Annual Meeting 2012 on April 1, 2012 3:15:00 PM-5:25:00 PM
Clinical Trials Symposium 1: Clinical Trials of Agents Directed Towards PI3K and Metabolic Pathways
Free
Some slides withheld
 
 
Discussant
Carlos L. Arteaga
Vanderbilt-Ingram Cancer Ctr., Nashville, TN, United States
 
from the AACR Annual Meeting 2012 on April 1, 2012 3:15:00 PM-5:25:00 PM
Clinical Trials Symposium 1: Clinical Trials of Agents Directed Towards PI3K and Metabolic Pathways
 
 
Permission not
granted for webcast
 
 
A phase II study of neoadjuvant metformin in prostatic carcinoma
Anthony M. Joshua
Princess Margaret Hospital, Toronto, ON, Canada
 
from the AACR Annual Meeting 2012 on April 1, 2012 3:15:00 PM-5:25:00 PM
Clinical Trials Symposium 1: Clinical Trials of Agents Directed Towards PI3K and Metabolic Pathways
Free
Some slides withheld
 
 
Discussant
Howard Scher
Memorial Sloan Kettering Cancer Center, NY, United States
 
from the AACR Annual Meeting 2012 on April 1, 2012 3:15:00 PM-5:25:00 PM
Advances in Chemoprevention
Paid users only
Available
All slides included
 
 
Breast cancer prevention: Targeting hormone and signaling pathways
Powel H. Brown
UT MD Anderson Cancer Ctr., Houston, TX, United States
 
from the AACR Annual Meeting 2012 on March 31, 2012 8:00:00 AM-10:00:00 AM
<< first | < prev page: of 144 records per page: next > | last >>
 
pages: 1 2 3 4 5 ... 141 142 143 144 presentations: 1 to 25 of 3593
 
©2001-2011 American Association for Cancer Research | 615 Chestnut St. 17th Floor, Philadelphia, PA 19106
Terms of Service | Switch to Mobile Version